The Price of Life
Recommend on Google+
One of the modules I found most interesting during my university days was The Economics of Social Policy. One of the topics we studied was how economists place a value upon human life.
This problem of placing a value on human life and which drugs should be made avaliable is looked at in a BBC 2 program this coming Wednesday.
On a finite budget, the NHS cannot afford to offer every treatment on the market, so how is it decided which medications should be made available?
Award-winning director Adam Wishart follows the nail-biting decision about one drug, with unprecedented access to decision-makers the National Institute for Health and Clinical Excellence, the patients who need a life-extending treatment, and the American company that discovered and will profit from it.
Adam Wishart also appeared on Start the Week this morning.
blog comments powered by Disqus
TEACHER RESOURCE NEWSLETTER FOR IB DIPLOMA - ADD YOUR DETAILS


